BridgeBio Oncology Therapeutics Inc. (BBOT) annual balance sheet — 5-year assets, liabilities & equity history
| Total Current Assets | 266.5M | 425.46M | 1.95M | 0 | 0 | 0 |
| Cash & Short-Term Investments | 252.28M | 425.46M | 1.7M | 0 | 0 | 0 |
| Cash Only | 52.66M | 373.69M | 1.7M | 0 | 0 | 0 |
| Short-Term Investments | 199.62M | 51.77M | 0 | 0 | 0 | 0 |
| Accounts Receivable | 146K | 386K | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - |
| Other Current Assets | 14.08M | -386K | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 151.14M | 22.92M | 192.47M | 332.89K | 144.58K | 144.28K |
| Property, Plant & Equipment | 3.16M | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | 0.00x | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 136.88M | 132K | 192.45M | 0 | 0 | 0 |
| Other Non-Current Assets | 11.24M | 22.79M | 25.13K | 332.89K | 144.58K | 144.28K |
| Total Assets | 417.65M | 448.38M | 194.42M | 332.89K | 144.58K | 144.28K |
| Asset Turnover | 0.00x | - | - | - | - | - |
| Asset Growth % | 441.08% | 130.62% | 58304.24% | 130.25% | 0.21% | - |
| Total Current Liabilities | 43.26M | 35.04M | 187.51K | 396.46K | 166.46K | 162.64K |
| Accounts Payable | 12.09M | 1.37M | 0 | 0 | 0 | 0 |
| Days Payables Outstanding | 9.47K | - | - | - | - | - |
| Short-Term Debt | 538K | 522K | 0 | 70.09K | 43.11K | 36.96K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 28.61M | 33.15M | 0 | 0 | 0 | 0 |
| Current Ratio | 6.16x | 12.14x | 10.40x | - | - | - |
| Quick Ratio | 6.16x | 12.14x | 10.40x | - | - | - |
| Cash Conversion Cycle | - | - | - | - | - | - |
| Total Non-Current Liabilities | 2.11M | 2.24M | 5.52M | 0 | 0 | 0 |
| Long-Term Debt | 0 | 2.24M | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 7M | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 5.52M | 0 | 0 | 0 |
| Total Liabilities | 45.37M | 37.28M | 5.71M | 396.46K | 166.46K | 162.64K |
| Total Debt | 2.64M | 2.77M | 0 | 70.09K | 43.11K | 36.96K |
| Net Debt | -50.01M | -370.92M | -1.7M | 70.09K | 43.11K | 36.96K |
| Debt / Equity | 0.01x | 0.01x | - | - | - | - |
| Debt / EBITDA | -0.02x | - | - | - | - | - |
| Net Debt / EBITDA | 0.30x | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - |
| Total Equity | 372.28M | 411.1M | 188.72M | -63.57K | -21.88K | -18.36K |
| Equity Growth % | 319.64% | 117.84% | 296969.04% | -190.57% | -19.18% | - |
| Book Value per Share | 11.95 | 13.20 | 11.34 | -0.00 | -0.00 | -0.00 |
| Total Shareholders' Equity | 372.28M | 411.1M | 188.72M | -63.57K | -21.88K | -18.36K |
| Common Stock | 8K | 8K | 192.45M | 460 | 288 | 288 |
| Retained Earnings | -398.67M | -356.57M | -3.73M | -88.57K | -46.88K | -43.36K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -981K | 16K | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying BBOT stock.
As of 2025, BridgeBio Oncology Therapeutics Inc. (BBOT) had total assets of $448.4M including $425.5M in current assets.
BridgeBio Oncology Therapeutics Inc. (BBOT) carries total debt of $2.8M, offset by $425.5M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
BridgeBio Oncology Therapeutics Inc. (BBOT) has total shareholders' equity (book value) of $411.1M ($13.20 book value per share). Book value represents the net worth of the company belonging to common stock holders.
BridgeBio Oncology Therapeutics Inc. (BBOT) reported a current ratio of 12.14x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.